C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
12/2006
12/13/2006	CN1289486C Pyrimidine derivatives as regulating agent of insulin-like growth factor-1 receptor (igf-1)
12/13/2006	CN1289479C 5-cyclo indole compounds as 5-HT receptor ligands
12/13/2006	CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006	CN1289455C 2-(2,6-dichlorophenyl)-diarylimidazoles
12/12/2006	US7148357 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
12/12/2006	US7148274 Heat and oxidation resistance; photostability for polymers
12/12/2006	US7148252 Therapy or prphylaxis of primary brain cancer or a brain metastasis in a patient, comprising administering benzopyranones derivatives or their pharmaceutically acceptable salts
12/12/2006	US7148240 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
12/12/2006	US7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
12/12/2006	US7148237 Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
12/12/2006	US7148226 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
12/12/2006	US7148224 Pyrazinone derivatives
12/12/2006	US7148221 Vanilloid receptor ligands and their use in treatments
12/12/2006	CA2268314C Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems
12/12/2006	CA2257931C Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
12/07/2006	WO2006130075A1 Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
12/07/2006	WO2006129587A1 Pharmaceutical composition comprising pyrazolone derivative
12/07/2006	WO2006129583A1 Pyrazolone derivative
12/07/2006	WO2006129100A1 Novel compounds
12/07/2006	WO2006100082A3 Substituted oxindol derivatives, drugs containing said derivatives and the use thereof
12/07/2006	WO2006100081A3 Substituted oxindole derivatives, medicaments containing the latter and use thereof
12/07/2006	WO2006057977A3 Cycloalkyl piperidine tachykinin receptor antagonists
12/07/2006	US20060276524 2-(2,5-Dioxoimidazolidin-4-yl)-N-[2-(4'-fluoro-biphenyl-4-yl)-ethyl]-acetamide; asthma, chronic obstructive pulmonary disease, arthritis, atherosclerosis, restenosis; potent and highly selective inhibitors
12/07/2006	US20060276523 Nitoroxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-II receptor blockers for the treatment of cardiovascular diseases
12/07/2006	US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/07/2006	US20060276516 Inhibitors of kinases and treatment of diseases mediated by cytokines produced by p38
12/07/2006	US20060276514 Tyrosine kinase inhibitors
12/07/2006	US20060276511 Inhibitors of HCV replication
12/07/2006	US20060276504 N,N-Dibutyl-2-[3-(2,2-dimethylpropanoyl)-6-methoxy-1H-indazol-1-yl]acetamide; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, intraoccular pressure in the eye
12/07/2006	US20060276494 Novel sulfonamides as L-CPT1 inhibitors
12/07/2006	US20060276492 Treating human immunodeficiency and hepatitis B infections; high activity, low toxicity
12/07/2006	US20060276488 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis.
12/07/2006	US20060276487 New compounds useful for DPP-IV enzyme inhibition
12/07/2006	US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
12/07/2006	US20060276454 Monoamine re-uptake inhibitors and methods relating thereto
12/07/2006	US20060276434 3-Carbonylaminothiophenes and their use as fungicides
12/07/2006	CA2610671A1 Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
12/06/2006	EP1727816A1 Silylated carboxamides
12/06/2006	EP1727812A1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
12/06/2006	EP1727808A2 Biaryl amino acids and their use in dna binding oligomers
12/06/2006	EP1291343B1 Hydroxyformamidine derivatives and medicines containing the same
12/06/2006	CN1875026A Platinum complex and luminescent element
12/06/2006	CN1288150C Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases
12/06/2006	CN1288145C Synthesis method of Gabitril and its racemate and S-configuration
12/06/2006	CN1288138C 4,5-disubstituted-1,8-naphthoyl imide compounds and use thereof
12/06/2006	CN1288137C 7-heterocyclyl quinoline and thieno[2,3,-b] pyridine derivatives useful as antagonists of gonadotropin releasing hormone
12/05/2006	US7144912 drugs such as (4-methoxy-5-(1H-indol-2yl-methylene)-2,2'-bi-1H-pyrrole) used as anticarcinogenic or antitumor agents
12/05/2006	US7144910 hydrolase enzyme antagonists such as N-{(6S,9R,11R)-2-[5-4-fluoroophenyl)-1-methyl-1H-pyrazol-3-yl]-5,6,7,8,9,10-hexahydro-6,9-methanobenzo[a][8]annulen-11-yl}-N'-(2,2,2-trifiuoroethyl)sulfamide that inhibit processing of amyloid precursor protein, useful in treating or preventing Alzheimer's disease
12/05/2006	US7144909 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
12/05/2006	US7144898 Indole derivatives for the treatment of depression and anxiety
12/05/2006	US7144896 heterocyclic imines such as 3-[6-(1-Methanesulfonyl-1-methyl-ethyl)-quinolin-8-yl]-N-[6-(4-methylsulfanyl-phenyl)-pyridin-3-yl]-benzamide, used as phosphodiesterases (pde4) inhibitors; side effect reduction
12/05/2006	US7144888 Vanilloid receptor ligands and their use in treatments
12/05/2006	US7144885 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
12/05/2006	US7144883 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
12/05/2006	CA2414936C Thiophene retinoids
12/05/2006	CA2396458C Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
11/2006
11/30/2006	WO2006127396A1 Par2-modulating compounds and their use
11/30/2006	WO2006127184A1 Process for preparation of sulfamide derivatives
11/30/2006	WO2006126939A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
11/30/2006	WO2006126695A1 Pyrazole compound and therapeutic agent for diabetes comprising the same
11/30/2006	WO2006126171A2 New antibiotic derivatives
11/30/2006	WO2006125972A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
11/30/2006	WO2006125687A1 Heteroaroyl-substituted serine amides
11/30/2006	WO2006125621A1 Substituted piperidines as renin inhibitors
11/30/2006	WO2006125324A1 Treatment of protein folding disorders
11/30/2006	WO2006111858A3 Bis-(coumarin) compounds with anti-inflammatory activity
11/30/2006	WO2006111662A3 4h-1,2,4-triazin-5-one derivatives, their preparation and their use as alpha 7 nicotinic acetylcholine receptors
11/30/2006	US20060270713 3-Aminopyrrolidines as inhibitors of monoamine uptake
11/30/2006	US20060270706 Cyclic amine derivative having heteroaryl ring
11/30/2006	US20060270649 Azetidine derivatives, their preparation and medicaments containing them
11/30/2006	US20060267488 electroluminescent thin films containing anthracene derivatives between anodes and cathodes, used as light emitters ahving efficiency and durability
11/30/2006	DE102005024245A1 Thienopyridine Thienopyridines
11/30/2006	CA2609980A1 Treatment of protein folding disorders
11/30/2006	CA2609747A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphthalene derivatives modulating the 5ht6 receptor
11/30/2006	CA2609394A1 Pyrazole compound and therapeutic agent for diabetes comprising the same
11/30/2006	CA2609392A1 Modulators of atp-binding cassette transporters
11/30/2006	CA2609243A1 Heteroaroyl-substituted serine amides
11/30/2006	CA2609235A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
11/30/2006	CA2609185A1 Process for preparation of sulfamide derivatives
11/30/2006	CA2608687A1 New antibiotic derivatives
11/30/2006	CA2608685A1 Substituted piperidines as renin inhibitors
11/30/2006	CA2607280A1 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
11/29/2006	EP1726592A1 Dioxino derivatives and their use as dopanine agonists
11/29/2006	EP1726585A1 Diaryl-substituted five-membered heterocycle derivative
11/29/2006	EP1726584A1 2-aminoquinazoline derivative
11/29/2006	EP1726580A1 Aminophenylpropanoic acid derivative
11/29/2006	EP1725543A1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
11/29/2006	EP1725540A1 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
11/29/2006	EP1725538A1 Pyridazinone ureas as antagonists of a4 integrins
11/29/2006	EP1725535A2 Hiv integrase inhibitors
11/29/2006	EP1725528A2 Sulphonylpyrroles as hdac inhibitors
11/29/2006	EP1725236A1 Novel m3 muscarinic acetylcholine receptor antagonists
11/29/2006	EP1725232A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
11/29/2006	EP1725103A1 Substituted 4-(4-trifluoromethylpyrazolyl)-pyrimidines serving as herbicides
11/29/2006	EP1436288B1 Multi-functional thioxanthone photoinitiators
11/29/2006	EP1032559B1 Aminoalkylphenol derivatives for treating depression and memory dysfunction
11/29/2006	CN1871237A 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-IV inhibitors
11/29/2006	CN1871232A Benzimidazolyl derivatives
11/29/2006	CN1871231A 吡嗪衍生物及其医药用途 Pyrazine derivatives and pharmaceutical use
11/29/2006	CN1871225A Preferentially substituted calcium channel blockers

1 ... 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 ... 523